NicVAX - Wikipedia, the free encyclopedia
NicVAX is a nicotine conjugate vaccine intended to reduce or eliminate physical addiction to nicotine. According to the National Institute on Drug Abuse, NicVAX can potentially be ...
List of vaccine topics - Wikipedia, the free encyclopedia
People Developers of vaccines. Thomas Francis, Jr., MD; Maurice Hilleman; Edward Jenner, MD; Paul Offit, MD; Louis Pasteur, PhD; Albert Sabin, MD; Jonas Salk, MD
Efficacy of NicVAX in Smokers Who Want to Quit Smoking - Full Text ...
Sponsors and Collaborators: National Institute on Drug Abuse (NIDA) Nabi Biopharmaceuticals: Information provided by: National Institute on Drug Abuse (NIDA)
Safety and Effectiveness of NicVAX in Treating Nicotine Dependent ...
Sponsors and Collaborators: Nabi Biopharmaceuticals National Institute on Drug Abuse (NIDA) Information provided by: National Institute on Drug Abuse (NIDA)
Nabi Biopharmaceuticals Provides Update on Strategic Direction of ...
ROCKVILLE, Md., Jan. 25 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals (Nasdaq: NABI) today provided an update on the strategic direction of NicVAX(TM) (Nicotine Conjugate ...
Nabi Biopharmaceuticals Announces Successful Completion of NicVAX ...
Data Presented Today at the American Heart Association Scientific Sessions 2007 in Orlando, Florida Nabi Biopharmaceuticals today announced the successful compl
The Anti-Smoking Vaccine | DrugReporter | AlterNet
Although NicVAX does last a long time, the effects are not lifelong, so the treatment should be reversible in time. Preliminary studies have shown that a treatment of NicVAX lasts ...
Is a Nicotine Vaccine the Magic Bullet for Smoking Cessation, Health ...
Even if NicVAX was shown to be effective in preventing and treating nicotine addiction, access to it might be limited. Experimental drugs such as NicVAX might not be covered ...
Nabi Biopharmaceuticals Receives NIDA Grant to Fund NicVAX(TM ...
-- Grant Enables Nabi Biopharmaceuticals to Advance NicVAX To Phase III Pivotal Trials -- BOCA RATON, Fla., Sept. 12 /PRNewswire-FirstCall/ -- Nabi ...
Nabi Biopharmaceuticals Announces Successful Final Results of NicVAX(r ...
Nabi Biopharmaceuticals (Nasdaq:NABI) announced today positive final results from its Phase 2 NicVAX(r) (Nicotine Conjugate Vaccine) schedule optimization immunogenicity study to ...
